Outcomes of Anterior Chamber, Sulcus, and Pars Plana Glaucoma Drainage Device Placement in Glaucoma Patients.

Autor: Samuel S; Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA., Chang EK; Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA., Gupta S; Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA., Chachanidze M; Massachusetts Eye and Ear, Boston, MA, USA., Neeson CE; Massachusetts Eye and Ear, Boston, MA, USA., Miller JB; Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA., Chang TC; Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, USA., Solá-Del Valle DA; Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA.
Jazyk: angličtina
Zdroj: Journal of ophthalmology [J Ophthalmol] 2022 Jul 20; Vol. 2022, pp. 5947992. Date of Electronic Publication: 2022 Jul 20 (Print Publication: 2022).
DOI: 10.1155/2022/5947992
Abstrakt: Purpose: To assess outcomes of anterior chamber (AC), sulcus, and pars plana (PP) glaucoma drainage device (GDD) placement in glaucoma patients. Patients and Methods . Retrospective evaluation of glaucoma patients who underwent GDD insertion in the AC, sulcus, or PP at Massachusetts Eye and Ear between November 2016 and May 2021. Patients who received AC, sulcus, and pars plana tubes were selected using simple random sampling, and the first 40 patients meeting inclusion criteria were analyzed. Main outcome measures were cumulative success probabilities from Kaplan-Meier (KM) analyses, intraocular pressure (IOP), medication burden, and complication rates.
Results: The PP group had a larger proportion of Ahmed GDDs and was younger on average with less severe glaucoma compared to patients with AC or sulcus tubes. The PP group had a higher proportion of mixed-mechanism glaucoma and lower proportion of primary open-angle glaucoma. With success defined as IOP reduction ≥20% and 5 < IOP ≤ 21 mm Hg, the Kaplan-Meier cumulative success probabilities for all three GDD locations were not significantly different. No significant differences were found in complication rates between all groups after 3 months. Patients with PP GDD had significantly lower medication burden than those with AC or sulcus GDDs up to 1.5 years postoperatively (1.7 ± 1.1, 3.0 ± 1.4, and 2.8 ± 1.2 for PP, AC, and sulcus, respectively; P =0.017).
Conclusion: PP GDDs may be more effective in lowering medication burden than AC or sulcus tubes without compromising long-term safety.
Competing Interests: Dr. David A. Solá-Del Valle received Allergan (an AbbVie company) XEN Gel Stent lecture fees.
(Copyright © 2022 Sandy Samuel et al.)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje